Qiagen's Q4 Revenues Drop 1 Percent
February 01, 2011
Qiagen's Q4 Revenues Drop 1 Percent
The firm missed analysts' consensus estimate for the quarter, but its revenues were in line with its guidance of between $275 million and $290 million. For full-year 2010, its revenues were up 8 percent.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Hologic Women's Health Deal with Quest Viewed as Loss for Qiagen, Particularly on HPV Front
June 13, 2013 / PCR Insider - Qiagen, BioBay Open Translational Medicine Center in China
May 24, 2013 / GenomeWeb Daily News - Molecular Diagnostics Lifts Qiagen's Q1 Revenues 2 Percent
April 30, 2013 / GenomeWeb Daily News - Trovagene's Q4 Revenues, Loss Rise
April 2, 2013 / GenomeWeb Daily News - Epigenomics' 2012 Revenues Dip 29 Percent
March 21, 2013 / GenomeWeb Daily News